Opportunity Information: Apply for PAR 21 121
The National Institutes of Health (NIH), through the National Center for Advancing Translational Sciences (NCATS), is offering a limited-competition Funding Opportunity Announcement (FOA) called the Small Grant Program for the Clinical and Translational Science Award (CTSA) Program using the R03 mechanism (clinical trial optional). This opportunity, listed as PAR-21-121 (CFDA 93.350), is designed to help a specific group of early-stage investigators strengthen their research independence by generating the kind of preliminary results that can support a later, larger application such as an R01 or an equivalent award. In practical terms, the FOA is focused on helping NCATS CTSA Program KL2 scholars, along with individuals supported by CTSA-funded diversity supplements and re-entry supplements, build momentum as they move from mentored or supplement-supported roles into fully independent academic translational scientist careers.
The program supports small, self-contained clinical and translational science projects that can be completed relatively quickly and with modest resources. The FOA explicitly highlights several types of projects that fit the R03 scope: pilot and feasibility studies, secondary analyses of existing datasets, compact research projects with clearly defined aims, and work focused on developing or refining research methods or new research technologies. Importantly, the proposed research may include patient-oriented research, but it does not have to; the emphasis is on translational science broadly and on producing credible, fundable preliminary evidence or proof-of-concept results. The R03 format is meant to reduce barriers to launching a focused line of inquiry, allowing investigators to test an approach, establish feasibility, or validate a method before pursuing a more resource-intensive follow-on study.
Eligibility is broad at the organizational level, consistent with many NIH grant programs, and includes a wide range of U.S.-based entities such as state, county, and local governments; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; special district governments; public housing authorities/Indian housing authorities; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized tribal governments; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); and small businesses. The FOA also calls out additional eligible applicant categories that NIH often highlights for inclusivity and reach, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), certain Indian/Native American Tribal Governments that are not federally recognized, faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it clearly limits foreign participation: non-U.S. (foreign) institutions cannot apply as applicant organizations, and non-U.S. components of U.S. organizations are not eligible. However, “foreign components” as NIH defines them in the NIH Grants Policy Statement may be allowed, meaning a U.S. applicant may be able to include certain well-justified international elements under NIH rules even though a foreign institution cannot be the applicant.
From a funding standpoint, the award ceiling is listed as $50,000, reflecting the small-grant nature of the R03 mechanism and reinforcing the expectation that projects should be tightly scoped and achievable without extensive infrastructure or long timelines. The overall intent is capacity-building for translational researchers in the CTSA ecosystem: applicants are expected to use this short, targeted funding to produce publishable findings, feasibility metrics, validated tools or workflows, or other tangible outputs that make a subsequent larger grant application substantially more competitive.
Key administrative details included in the source information are that the agency is NIH, the opportunity category is discretionary, the funding instrument is a grant, and the activity category is health. The original closing date shown is October 17, 2023, and the FOA was created on January 4, 2021. Since NIH opportunities can have multiple receipt dates, revisions, or expiration dates depending on the announcement, anyone planning to apply would typically confirm the current status and active due dates in the official NIH/Grants.gov listing for PAR-21-121 and review the full FOA text for the limited-competition requirements tied specifically to CTSA KL2 scholars and CTSA-supported diversity or re-entry supplement recipients.Apply for PAR 21 121
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.350.
- This funding opportunity was created on 2021-01-04.
- Applicants must submit their applications by 2023-10-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Building Forensic Accounting Capacity in Serbia
Previous opportunity: Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 21 121
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 21 121) also looked into and applied for these:
| Funding Opportunity |
|---|
| New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 006 Funding Number: RFA AG 22 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed) Apply for RFA AI 21 001 Funding Number: RFA AI 21 001 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 21 010 Funding Number: RFA RM 21 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 21 009 Funding Number: RFA RM 21 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed) Apply for RFA RM 21 008 Funding Number: RFA RM 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 033 Funding Number: RFA AG 21 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) Apply for PAR 21 089 Funding Number: PAR 21 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) Apply for PAR 21 109 Funding Number: PAR 21 109 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) Apply for RFA TR 21 010 Funding Number: RFA TR 21 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed) Apply for PAR 21 108 Funding Number: PAR 21 108 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 21 083 Funding Number: PAR 21 083 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) Apply for PAR 21 082 Funding Number: PAR 21 082 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) Apply for PAR 21 118 Funding Number: PAR 21 118 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional) Apply for RFA TR 21 008 Funding Number: RFA TR 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional) Apply for RFA AG 21 034 Funding Number: RFA AG 21 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) Apply for PAR 21 119 Funding Number: PAR 21 119 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required) Apply for PAR 21 096 Funding Number: PAR 21 096 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 21 139 Funding Number: PAR 21 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Clinical Trial Not Allowed) Apply for PAR 21 095 Funding Number: PAR 21 095 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required) Apply for PAR 21 094 Funding Number: PAR 21 094 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 121", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
